000 01668 a2200433 4500
005 20250514222319.0
264 0 _c20050425
008 200504s 0 0 eng d
022 _a0008-5472
024 7 _a10.1158/0008-5472.CAN-04-3606
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLi, Zhijie
245 0 0 _aGenetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death.
_h[electronic resource]
260 _bCancer research
_cMar 2005
300 _a2070-5 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBrain-Derived Neurotrophic Factor
_xantagonists & inhibitors
650 0 4 _aCell Death
_xdrug effects
650 0 4 _aCell Line, Tumor
650 0 4 _aChromones
_xpharmacology
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aHumans
650 0 4 _aMorpholines
_xpharmacology
650 0 4 _aNeuroblastoma
_xdrug therapy
650 0 4 _aPhosphatidylinositol 3-Kinases
_xmetabolism
650 0 4 _aPhosphorylation
650 0 4 _aProtein Serine-Threonine Kinases
_xantagonists & inhibitors
650 0 4 _aProto-Oncogene Proteins
_xantagonists & inhibitors
650 0 4 _aProto-Oncogene Proteins c-akt
650 0 4 _aReceptor, trkB
_xmetabolism
650 0 4 _aSignal Transduction
650 0 4 _aTransfection
700 1 _aJaboin, Jerry
700 1 _aDennis, Phillip A
700 1 _aThiele, Carol J
773 0 _tCancer research
_gvol. 65
_gno. 6
_gp. 2070-5
856 4 0 _uhttps://doi.org/10.1158/0008-5472.CAN-04-3606
_zAvailable from publisher's website
999 _c15453502
_d15453502